Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Patricia Peking, Thomas Kocher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic AutoantibodiesMichele M Luchetti, Gianluca Moroncini, Maria Jose Escamez, et al.
Molecular Therapy. Nucleic Acids|July 21, 2025
Targeting olfactory receptor OR2AT4: An innovative aptamer-based treatment for hair growth promotionManuel Mataix, Nuria Illera, Inés Hidalgo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 14, 2013
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombinationAndrea Coluccio, Francesca Miselli, Angelo Lombardo, et al.
Oncogene|January 16, 2002
Functional roles of Akt signaling in mouse skin tumorigenesisCarmen Segrelles, Sergio Ruiz, Paloma Perez, et al.
Gene Therapy|August 7, 2021
Non-viral delivery of CRISPR-Cas9 complexes for targeted gene editing via a polymer delivery systemJonathan O'Keeffe Ahern, Irene Lara-Sáez, Dezhong Zhou, et al.
The Journal of Investigative Dermatology|January 11, 2008
Assessment of optimal virus-mediated growth factor gene delivery for human cutaneous wound healing enhancementMaría J Escámez, Marta Carretero, Marta García, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cellsEmilie Warrick, Marta Garcia, Corinne Chagnoleau, et al.
Molecular Therapy. Methods & Clinical Development|October 10, 2022
Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectorsMarta García, Jose Bonafont, Jesús Martínez-Palacios, et al.
Cancer Research|August 18, 2004
Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factorMarta Garcia, Nuria Isabel Fernandez-Garcia, Veronica Rivas, et al.
Pageof 7